Literature DB >> 29733234

Glycosylation of random IgG distinguishes seropositive and seronegative rheumatoid arthritis.

I Magorivska1, B Döncző2, T Dumych3, A Karmash3, M Boichuk3, K Hychka3, M Mihalj4,5, M Szabó6, E Csánky6, J Rech1, A Guttman2,7, S G Vari8, R Bilyy1,4.   

Abstract

The N-glycosylation of human immunoglobulins, especially IgGs, plays a critical role in determining affinity of IgGs towards their effector (pro- and anti-inflammatory) receptors. However, it is still not clear whether altered glycosylation is involved in only antibody-dependent disorders like seropositive rheumatoid arthritis (RA) or also in pathologies with similar clinical manifestations, but no specific autoantibodies like seronegative RA. The clarification of that uncertainty was the aim of the current study. Another study aim was the detection of specific glycan forms responsible for altered exposure of native glycoepitopes. We studied sera from seropositive RA (n = 15) and seronegative RA (n = 12) patients for exposure of glycans in native IgG molecules, followed by determination of specific glycans by capillary electrophoresis with laser-induced fluorescent detection (CE-LIF). Aged-matched groups of normal healthy donors (NHD) and samples of intravenous immunoglobulin IgG preparations (IVIG) served as controls. There was significantly stronger binding of Lens culinaris agglutinin (LCA) and Aleuria aurantia lectin (AAL) lectins towards IgG from seropositive RA compared to seronegative RA or NHD. CE-LIF analysis revealed statistically significant increases in bisecting glycans FA2BG2 (p = .006) and FABG2S1 (p = .005) seropositive RA, accompanied by decrease of bisecting monogalactosylated glycan FA2(6)G1 (p = .074) and non-bisecting monosialylated glycan FA2(3)G1S1 (p = .055). The results suggest that seropositive RA is distinct from seronegative RA in terms of IgG glycan moieties, attributable to specific immunoglobulin molecules present in seropositive disease. These glycans were determined to be bisecting GlcNAc-bearing forms FA2BG2 and FABG2S1, and their appearance increased the availability of LCA and AAL lectin-binding sites in native IgG glycoepitopes.

Entities:  

Keywords:  ELISA; Immunoglobulin; glycosylation; lectins; rheumatoid arthritis

Mesh:

Substances:

Year:  2018        PMID: 29733234     DOI: 10.1080/08916934.2018.1468886

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

Review 1.  Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective.

Authors:  Konstantinos Flevaris; Cleo Kontoravdi
Journal:  Int J Mol Sci       Date:  2022-05-06       Impact factor: 6.208

2.  Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood.

Authors:  Clizia Chinello; Noortje de Haan; Giulia Capitoli; Barbara Trezzi; Antonella Radice; Lisa Pagani; Lucrezia Criscuolo; Stefano Signorini; Stefania Galimberti; Renato Alberto Sinico; Manfred Wuhrer; Fulvio Magni
Journal:  Int J Mol Sci       Date:  2022-04-23       Impact factor: 6.208

Review 3.  Monitoring of immunoglobulin N- and O-glycosylation in health and disease.

Authors:  Noortje de Haan; David Falck; Manfred Wuhrer
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

4.  The B-Cell-Specific Ablation of B4GALT1 Reduces Cancer Formation and Reverses the Changes in Serum IgG Glycans during the Induction of Mouse Hepatocellular Carcinoma.

Authors:  Jichen Sha; Rongrong Zhang; Jiteng Fan; Yong Gu; Yiqing Pan; Jing Han; Xiaoyan Xu; Shifang Ren; Jianxin Gu
Journal:  Cancers (Basel)       Date:  2022-03-04       Impact factor: 6.639

Review 5.  Glycosylation Biomarkers Associated with Age-Related Diseases and Current Methods for Glycan Analysis.

Authors:  Beatrix Paton; Manuel Suarez; Pol Herrero; Núria Canela
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.